| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/26/2009 | DE202008017181U1 Aliquotiereinrichtung Aliquotiereinrichtung |
| 03/26/2009 | DE202008016301U1 Bestätigungstest für den serologischen Borrelia burgdorferi sensu lato-Nachweis mit zusätzlicher Nachweisfunktion zur Erkennung von Treponema pallidum-Infektionen Confirmatory test for the serological Borrelia burgdorferi sensu lato detection with additional proof function to detect Treponema pallidum infections |
| 03/26/2009 | DE102004040455B4 Kontinuierliches Mischen zur Gasanalysatorkalibrierung Continuous mixing of Gasanalysatorkalibrierung |
| 03/26/2009 | CA2803927A1 Microfluidic device and method for fluid clotting time determination |
| 03/26/2009 | CA2742177A1 Method for determining carbon content of a hydrocarbon-containing mixture |
| 03/26/2009 | CA2705306A1 Neoepitope detection of disease using protein arrays |
| 03/26/2009 | CA2700476A1 Methods and compositions for detection of ehrlichia chaffeensis (vlpt) |
| 03/26/2009 | CA2700474A1 Methods and compositions for detection of ehrlichia chaffeensis (p120) |
| 03/26/2009 | CA2700200A1 Identification of novel pathways for drug development for lung disease |
| 03/26/2009 | CA2700128A1 Method of altering the binding specificity of monoclonal antibodies by oxidation-reduction reactions |
| 03/26/2009 | CA2700125A1 Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast |
| 03/26/2009 | CA2700115A1 Long interspersed nuclear element polypeptide compositions and methods of use thereof |
| 03/26/2009 | CA2700064A1 Gas sensor |
| 03/26/2009 | CA2699958A1 Identification and isolation of fetal cells and nucleic acid |
| 03/26/2009 | CA2699828A1 Method for measuring substrate concentration and device for the same |
| 03/26/2009 | CA2699760A1 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 03/26/2009 | CA2699394A1 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
| 03/26/2009 | CA2699315A1 Self-actuating signal producing detection devices and methods |
| 03/26/2009 | CA2698899A1 Assessing congestive heart risk in patients treated or potentially to be treated with a peroxisome-proliferator-activator-receptor-gamma agonist or a thiazolidinedione |
| 03/26/2009 | CA2698616A1 Ed-b fibronectin as stratification marker for anti-tumor drugs |
| 03/26/2009 | CA2694494A1 Hpiv-2 variants and medical applications thereof |
| 03/26/2009 | CA2688558A1 Biomarker combinations for colorectal cancer |
| 03/25/2009 | EP2040198A1 Ray-based image analysis for biological specimens |
| 03/25/2009 | EP2040078A1 Method for quantifying phosphokinase activity on proteins |
| 03/25/2009 | EP2040077A1 Method for producing an immobilization substrate and immobilization substrate produced by the method |
| 03/25/2009 | EP2040076A2 Substrate and method for producing the substrate |
| 03/25/2009 | EP2040075A1 Compounds and markers for surface-enhanced raman scattering |
| 03/25/2009 | EP2040074A1 Protein assay method, indicator for protein assay, and test piece for protein assay |
| 03/25/2009 | EP2040073A1 Microfluidic device and method for fluid clotting time determination |
| 03/25/2009 | EP2040071A2 Gas sorption tester for rapid screening of multiple samples |
| 03/25/2009 | EP2040068A2 Nucleic acid detection sensor |
| 03/25/2009 | EP2040065A1 Method and apparatus for measuring liquid sample |
| 03/25/2009 | EP2040060A1 Apparatus and method for detecting target substance, or device used for these apparatus and method |
| 03/25/2009 | EP2039782A2 Method and apparatus for judging the presence or absence of cancer cell |
| 03/25/2009 | EP2039779A1 Screening method |
| 03/25/2009 | EP2039769A2 Antimicrobial peptides and methods of use |
| 03/25/2009 | EP2039765A1 Method for determination of 1,5-anhydroglucitol, and reagent composition for determination of 1,5-anhydroglucitol |
| 03/25/2009 | EP2039762A2 Nitralases |
| 03/25/2009 | EP2039703A1 Toxin detection method |
| 03/25/2009 | EP2039367A1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 03/25/2009 | EP2039256A1 Fruit juice apparatus with undesired material release detector and related methods |
| 03/25/2009 | EP2038900A2 A method for manipulating magnetic particles in a liquid medium |
| 03/25/2009 | EP2038660A2 A method for the presumptive detection of substances |
| 03/25/2009 | EP2038659A2 Method for identifying crmp modulators |
| 03/25/2009 | EP2038658A1 Assay device |
| 03/25/2009 | EP2038657A1 Assay device and method |
| 03/25/2009 | EP2038656A2 Ultra-sensitive detection of analytes |
| 03/25/2009 | EP2038655A2 Systems and methods for performing measurements of one or more materials |
| 03/25/2009 | EP2038654A1 Method of treating diseases with parp inhibitors |
| 03/25/2009 | EP2038652A2 Method for detecting il-16 activity and modulation of il-16 activity based on rantes proxy levels |
| 03/25/2009 | EP2038651A2 An in vitro method of detecting and/or diagnosing cancer using uv light based dna image cytometry |
| 03/25/2009 | EP2038650A1 Apparatus for collection and analysis of human body fluids |
| 03/25/2009 | EP2038649A2 Method for employing sec-ftir data to predict mechanical properties of polyethylene |
| 03/25/2009 | EP2038648A2 Electronic chain of custody systems&methods for use with drug testing |
| 03/25/2009 | EP2038647A2 Authentication of ingestible products using saccharides as markers |
| 03/25/2009 | EP2038635A2 A magnetic sensor device for and a method of sensing magnetic particles |
| 03/25/2009 | EP2038413A2 Apparatus, compositions, and methods for assessment of chronic obstructive pulmonary disease progression among rapid and slow decline conditions |
| 03/25/2009 | EP2038224A2 Mobile unit for the treatment of raw water |
| 03/25/2009 | EP2038074A2 Make and use of surface molecules of varied densities |
| 03/25/2009 | EP2038064A1 Apparatus and method for separating and concentrating fluids containing multiple components |
| 03/25/2009 | EP2038063A2 Disposable assay device with removables modules and remote data transfer system |
| 03/25/2009 | EP2038029A1 A method and device for extracting bitterness from beer |
| 03/25/2009 | EP2037944A2 Tacrolimus standard and methods of using same |
| 03/25/2009 | EP2037797A2 Method and apparatus for diagnosing pre-eclampsia |
| 03/25/2009 | EP2037729A1 System and method for managing animals on a dairy farm |
| 03/25/2009 | EP2000801A9 Body fluid components measuring device |
| 03/25/2009 | EP1982193A4 Cell classification system |
| 03/25/2009 | EP1977242A4 Lateral flow immunoassay with encapsulated detection modality |
| 03/25/2009 | EP1974213A4 High sensitivity secretagogin assays and their uses for diagnosis and/or prognosis |
| 03/25/2009 | EP1920239A4 Detection and measurement of blood-feeding activity |
| 03/25/2009 | EP1904854B1 Method for the identification of proteins folding inhibitors |
| 03/25/2009 | EP1899725A4 Nucleic acid biosensor with photoelectrochemical amplification |
| 03/25/2009 | EP1891395A4 Fiber-optic assay apparatus based on phase-shift interferometry |
| 03/25/2009 | EP1888775A4 Method for measuring effectively the activity of cytotoxic t lymphocyte in human and out-bred animals |
| 03/25/2009 | EP1871870A4 Method for enriching rare cell subpopulations from blood |
| 03/25/2009 | EP1869451A4 Monitoring and manipulating cellular transmembrane potentials using nanostructures |
| 03/25/2009 | EP1856503A4 Dual path immunoassay device |
| 03/25/2009 | EP1815022A4 Method of determining a cellular response to a biological agent |
| 03/25/2009 | EP1766401B1 Method for the simple and rapid detection of cells and biomolecules by means of paramagnetic particles |
| 03/25/2009 | EP1763672B1 Indicator strip and a device for automatic testing of liquids |
| 03/25/2009 | EP1711808A4 Method for measurement of immature granulocytes |
| 03/25/2009 | EP1650565B1 Surface of base material being inhibited in non-specific adsorption |
| 03/25/2009 | EP1634051A4 Ion-detecting sensors comprising plasticizer-free copolymers |
| 03/25/2009 | EP1633854B1 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 03/25/2009 | EP1556699B1 Method for ngf assay for in vitro diagnosis of breast cancer and therapeutic use |
| 03/25/2009 | EP1552302B1 Protein interaction difference mapping |
| 03/25/2009 | EP1551627A4 Method and composition for forming a protective coating on an assay substrate and substrate produced by the same |
| 03/25/2009 | EP1539791A4 Method for distinguishing ulcerative colitis from crohn s di sease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca) |
| 03/25/2009 | EP1512015B1 Methods for improving a binding characteristic of a molecule |
| 03/25/2009 | EP1499748B1 Hepatitis c virus assay systems |
| 03/25/2009 | EP1457572B1 Method of colorimetry and reagent for use therein |
| 03/25/2009 | EP1344055A4 Materials for enhancing staining of biopolymers in matrices |
| 03/25/2009 | EP1336104B1 Proteomics based drug comparison methods |
| 03/25/2009 | EP1325110A4 Automated bioculture and bioculture experiments system |
| 03/25/2009 | EP1319183B1 Methods and products related to low molecular weight heparin |
| 03/25/2009 | EP1242587B1 A NOVEL ISOFORM OF HUMAN cAMP-DEPENDENT PROTEIN KINASE, C ALPHA-s, LOCALIZES TO SPERM MIDPIECE AND THE USE THEREOF |
| 03/25/2009 | EP1238282B1 Methods of diagnosis and treatment by binding p75/airm1 |
| 03/25/2009 | EP1141291B1 Method for the cellular high-throughput-detection of nuclear receptor ligand interactions |
| 03/25/2009 | EP1110090B1 Multihued labels |
| 03/25/2009 | EP1105533B1 Vessel for blood sampling |